Prevision Medicine raises USD 5.4 M

Prevision Medicine tests living tumour cells from patients against a large library of treatments to guide therapy choice in oncology. The Zurich-based company has closed a USD 5.4 million seed round, led by ACE Ventures, to obtain approvals and reimbursement and expand in Europe.

Announced on
Round
Seed
Amount
USD 5.4 M
Location
Zurich
Sector
Health & medtech, Biotech & life sciences

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic